NCT01329822

Brief Summary

The aim of this randomized controlled study was to evaluate the effects of CR on circulating fetuin-A levels in obese humans with type 2 diabetes based on monitoring energy intake and energy expenditure by daily activity. Furthermore, the investigators examined the relationship between the changes of fetuin-A levels induced by CR and cardiovascular risk parameters including atherogenic lipid profile, visceral fat area (VFA), brachial artery endothelial function, and carotid IMT.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P50-P75 for not_applicable type-2-diabetes

Timeline
Completed

Started Mar 2010

Shorter than P25 for not_applicable type-2-diabetes

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2010

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2011

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 4, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 6, 2011

Completed
Last Updated

April 6, 2011

Status Verified

April 1, 2011

Enrollment Period

1 year

First QC Date

April 4, 2011

Last Update Submit

April 5, 2011

Conditions

Keywords

type 2 diabetesoverweight

Outcome Measures

Primary Outcomes (1)

  • Fetuin-A

    changes of fetuin-A levels induced by CR

    12 weeks

Secondary Outcomes (1)

  • cardiovascular risk factors

    12 weeks

Study Arms (2)

Caloric restriction group

EXPERIMENTAL

CR group were educated by a dietitian to reduce their usual energy intake to 1400 kcal/day (-500 kcal/day, -26% from baseline) for weight reduction and the recommended macronutrient composition was the 50-55% of energy intake as carbohydrate, 15-20% as protein and 20-25% as fat. Daily energy intake and nutrient composition were determined using a computer-aided nutritional analysis program (CAN-Pro 3.0; Korean Nutrition Society, Seoul, South Korea).

Behavioral: Caloric restriction

Control group

NO INTERVENTION

Control group - ad libitum diet

Interventions

Caloric restriction

Caloric restriction group

Eligibility Criteria

Age35 Years - 70 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • type 2 diabetes
  • BMI \>= 23 kg/m2
  • stable body weight (\<2 kg change in weight in the past 6 months)
  • sedentary lifestyle (\<20 min of exercise twice a week)

You may not qualify if:

  • smoking
  • cardiovascular disease
  • chronic kidney disease
  • chronic liver disease
  • pregnant or breast feeding
  • any major illness
  • taking medications that could affect laboratory test results

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Eulji University Hospital

Seoul, 139-711, South Korea

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Overweight

Interventions

Caloric Restriction

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsEnergy IntakeDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Kyung Wan Min

    Eulji University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 4, 2011

First Posted

April 6, 2011

Study Start

March 1, 2010

Primary Completion

March 1, 2011

Study Completion

March 1, 2011

Last Updated

April 6, 2011

Record last verified: 2011-04

Locations